The U.S. Food and Drug Administration classifies Lantus Solostar (insulin glargine) in pregnancy category C because studies do not adequately show whether this drug poses a risk to an unborn child. However, insulin is considered the best treatment for pregnant women who are diabetic. Uncontrolled diabetes can cause high blood sugar (hyperglycemia), which is associated with birth defects. It is unknown whether this drug can be passed in breast milk. Talk to your doctor if you plan on nursing or becoming pregnant while using Lantus Solostar.
Continue Learning about Antidiabetic
Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.